Research ArticleExclusivement sur le Web

La naltrexone et le bupropion pour la perte pondérale

Betsy Thomas, Adrienne J. Lindblad, Thao Luu and Allison Paige
Canadian Family Physician September 2023; 69 (9) e179-e180; DOI: https://doi.org/10.46747/cfp.6909e179
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson{at}gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Respond to this article
La naltrexone et le bupropion pour la perte pondérale
Betsy Thomas, Adrienne J. Lindblad, Thao Luu, Allison Paige
Canadian Family Physician Sep 2023, 69 (9) e179-e180; DOI: 10.46747/cfp.6909e179
Twitter logo Facebook logo Mendeley logo

Jump to section

Subjects